Literature DB >> 21531682

Validity of the Patient Generated Index as a quality-of-life measure in radiation oncology.

Susan S Tavernier1, Susan L Beck, Margaret F Clayton, Marjorie A Pett, Donna L Berry.   

Abstract

PURPOSE/
OBJECTIVES: To evaluate psychometric properties of an instrument designed to measure individualized health-related quality of life (HRQOL).
DESIGN: Repeated measures of self-reported quality of life.
SETTING: An outpatient radiation therapy department in the western part of the United States. SAMPLE: 86 adults with cancer receiving their first course of radiation therapy.
METHODS: The Patient Generated Index (PGI), the National Comprehensive Cancer Network's Distress Thermometer (DT), and the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core-30 (QLQ-C30). MAIN RESEARCH VARIABLES: Convergent validity, responsiveness, sensitivity, and response shift.
FINDINGS: PGI scores were inversely correlated with scores on the DT (r = -0.49, -0.55, -0.44; p < 0.001), as well as the role (r = 0.31, 0.4, 0.38; p < 0.01), emotional (r = 0.33, 0.41, 0.33; p < 0.01), social functioning (r = 0.27, 0.49, 0.42; p < 0.05), pain (r = -0.29, -0.39, -0.39; p < 0.01), and fatigue (r = -0.35, -0.25, -0.47; p < 0.05) QLQ-C30 subscales at all measurement times. The PGI was responsive to those reporting high or low DT scores (t = 4.42, 3.32, 2.9; p < 0.05). A small-to-moderate effect size was detected in those who had an increase (effect size = 0.51) or decrease (effect size = 0.38) in HRQOL over time. Participants reconceptualized HRQOL over time.
CONCLUSIONS: Data supported the PGI as a valid measure of individualized HRQOL. IMPLICATIONS FOR NURSING: The PGI potentially provides a more patient-centered measure of HRQOL in patients with cancer. Additional testing is needed in larger, more diverse groups.

Entities:  

Mesh:

Year:  2011        PMID: 21531682     DOI: 10.1188/11.ONF.319-329

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  7 in total

1.  Impact of reconceptualization response shift on rating of quality of life over time among people with advanced cancer.

Authors:  Ala' S Aburub; B Gagnon; S Ahmed; A M Rodríguez; Nancy E Mayo
Journal:  Support Care Cancer       Date:  2018-03-21       Impact factor: 3.603

Review 2.  A review of the application, feasibility, and the psychometric properties of the individualized measures in cancer.

Authors:  Ala' S Aburub; Nancy E Mayo
Journal:  Qual Life Res       Date:  2016-11-18       Impact factor: 4.147

3.  Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer.

Authors:  Ala' S Aburub; B Gagnon; A M Rodríguez; Nancy E Mayo
Journal:  Support Care Cancer       Date:  2015-06-23       Impact factor: 3.603

Review 4.  The current trend of administering a patient-generated index in the oncological setting: a systematic review.

Authors:  Jessica A Tang; Taemin Oh; Justin K Scheer; Andrew T Parsa
Journal:  Oncol Rev       Date:  2014-06-30

5.  Web-Based Health Coaching for Spinal Cord Injury: Results From a Mixed Methods Feasibility Evaluation.

Authors:  Sonya Allin; John Shepherd; Teri Thorson; Jennifer Tomasone; Sarah Munce; Gary Linassi; Christopher B McBride; Tizneem Jiancaro; Susan Jaglal
Journal:  JMIR Rehabil Assist Technol       Date:  2020-07-31

6.  Validation of an Individualized Measure of Quality of Life, Patient Generated Index, for Use with People with Parkinson's Disease.

Authors:  Ayse Kuspinar; Kedar K V Mate; Anne-Louise Lafontaine; Nancy Mayo
Journal:  Neurol Res Int       Date:  2020-03-30

7.  Do Generic Preference-Based Measures Accurately Capture Areas of Health-Related Quality of Life Important to Individuals with Amyotrophic Lateral Sclerosis: A Content Validation Study.

Authors:  Nicole Peters; Vanina Dal Bello-Haas; Tara Packham; Marvin Chum; Colleen O'Connell; Wendy S Johnston; Joy C MacDermid; John Turnbull; Jill Van Damme; Ayse Kuspinar
Journal:  Patient Relat Outcome Meas       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.